Patient Guide: A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 95 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06534983
Status: 🟢 Enrolling Now
Condition: Muscle Invasive Urothelial Carcinoma
Phase: PHASE2

Where You Can Participate

This study is available at 95 locations across the country.

Top locations include:
  • • Springdale, Arkansas
  • • Duarte, California
  • • Riverside, California
  • • And 92 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) - Join Clinical Trial NCTNCT06534983

How to Join This Clinical Trial - NCTNCT06534983

Learn how to participate in this PHASE2 trial studying an investigational therapy for Muscle Invasive Urothelial Carcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Muscle Invasive Urothelial Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Muscle Invasive Urothelial Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06534983 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 95 locations. Find a study site near you:

Clinical Research Site

Springdale, Arkansas 72762 - United States

Status: RECRUITING

Clinical Research Site

Duarte, California 91010 - United States

Status: RECRUITING

Clinical Research Site

Riverside, California 92505 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94158 - United States

Status: RECRUITING

Clinical Research Site

Washington, District of Columbia 20007 - United States

Status: RECRUITING

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: RECRUITING

Clinical Research Site

Detroit, Michigan 48202 - United States

Status: RECRUITING

Clinical Research Site

Basking Ridge, New Jersey 07920 - United States

Status: SUSPENDED

Clinical Research Site

Middletown, New Jersey 07748 - United States

Status: SUSPENDED

Clinical Research Site

Montvale, New Jersey 07645 - United States

Status: SUSPENDED

And 85 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Muscle Invasive Urothelial Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships